Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]-AraG PET Imaging in Advanced NSCLC
NCT04186988Phase 1Withdrawn
- Sponsor
- University of California, Davis
- Start
- Nov 2019
- Primary completion
- Mar 2020
01
Overview
Phase 1, open-label, single-arm trial of fluorine f 18 ara-g in non-small cell lung cancer (NSCLC), sponsored by University of California, Davis. Primary endpoint: Standardized Uptake Value at 2 weeks. Planned start Nov 2019; status: withdrawn.
02
Drugs
fluorine f 18 ara-g
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04186988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04186988.